non-Hodgkins lymphoma non-Hodgkins lymphoma
Stories About

non-Hodgkins lymphoma

Katie Pope Kopp, 64, of Parkville, Mo., at Union Station in Kansas City this week. Kopp underwent a new form of experimental CAR T-cell therapy that used the CRISPR gene-editing technique to treat her non-Hodgkin lymphoma. The cancer has been in remission for over a year. Barrett Emke for NPR hide caption

toggle caption
Barrett Emke for NPR

CRISPR gene-editing may boost cancer immunotherapy, new study finds

  • Download
  • <iframe src="https://www.npr.org/player/embed/1140384354/1142418973" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The 84-year-old actor said in an Instagram post Friday, Sept. 2, 2022, that she has been diagnosed with non-Hodgkin lymphoma and has begun a six-month course of chemotherapy. Richard Shotwell/Richard Shotwell/Invision/AP hide caption

toggle caption
Richard Shotwell/Richard Shotwell/Invision/AP

A jury in federal court in San Francisco on Tuesday concluded that Roundup weed killer was a substantial factor in a California man's cancer. The company denies the connection. Haven Daley/AP hide caption

toggle caption
Haven Daley/AP